Cellnovo Stock

Stocks

CLNV

FR0012633360

Software

Real-time Euronext Paris 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Cellnovo -.--% -

Valuation: Cellnovo

Market Cap 2.44M 2.12M 1.98M 1.81M 3.42M 232M 3.48M 23.3M 9.13M 116M 9.15M 8.95M 382M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.83M 10.11M 9.28M 17.5M 1.19B 17.8M 119M 46.68M 592M 46.79M 45.76M 1.95B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
+2.90%+6.34% - - 22.36B
-0.85%+0.29%-29.52%+1.15% 15.96B
-0.65%+20.31%+20.61%+106.31% 8.21B
+7.46%+15.86%-44.31%-54.06% 7.89B
-0.31%+10.79%-34.39%+234.99% 4.38B
+0.35%+13.18%-31.99%-17.24% 2.49B
0.00%+12.94%-32.63%-36.84% 2B
+1.76%+6.66%+33.17%+93.31% 1.63B
+1.68%+5.30%+4.93%+47.13% 1.43B
Average +2.06%+6.51%-14.27%+46.84% 6.63B
Weighted average by Cap. +2.66%+6.07%-20.14%+36.29%

Financials

2018 2019 *
Net sales 3.32M 2.89M 2.7M 2.47M 4.67M 317M 4.75M 31.78M 12.45M 158M 12.48M 12.2M 521M -
Net income -15.94M -13.85M -12.93M -11.87M -22.39M -1.52B -22.78M -152M -59.73M -758M -59.87M -58.54M -2.5B -
Net Debt 10.02M 8.71M 8.13M 7.47M 14.08M 955M 14.32M 95.89M 37.55M 476M 37.65M 36.81M 1.57B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock